Dioxaphetyl butyrate

Dioxaphetyl butyrate
Systematic (IUPAC) name
	Ethyl 4-morpholin-4-yl-2,2-di(phenyl)butanoate
Clinical data
Legal status	AU: S9 (Prohibited); CA: Schedule I; DE: Anlage I (Controlled); US: Schedule I;
Routes of; administration	Oral, Other ROA Unknown
Identifiers
CAS Number	467-86-7
ATC code	none
PubChem	CID: 48194
UNII	G751H98FY4
Synonyms	Amidalgon, Spasmoxal
Chemical data
Formula	C22H27NO3
Molecular mass	353.45 g/mol
	SMILES CCOC(=O)C(CCN1CCOCC1)(c1ccccc1)c1ccccc1 ;
(what is this?) (verify)

Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol.

It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea.

In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9621 and a 2013 annual aggregrate manufacturing quota of zero.

References

Lua error in package.lua at line 80: module 'strict' not found.

This analgesic-related article is a stub. You can help Wikipedia by expanding it.